More importantly, we demonstrated that the synthetic cannabinoids show a pro-apoptotic efficacy also in the primary cultures of GBM-derived cells (T3 and T10 cell lines), in which we identified a functional p53 deficiency. Here, TP53 is linked to glioblastoma.